Vantia Limited
8Patents
6Active
8Granted
38Portfolio score
Filing activity: Mar 4, 2003 → Mar 30, 2012 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8183280B2 | FAP inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8202858B2 | Vasopressin V1a antagonists | Chemistry; Metallurgy | 3 | Active |
| US7560454B2 | Condensed azepines as vasopressin agonists | Chemistry; Metallurgy | 1 | Expired |
| US8063038B2 | Heterocyclic condensed compounds useful as antidiuretic agents | Chemistry; Metallurgy | 0 | Active |
| US7649000B2 | Selective dipeptide inhibitors of kallikrein | Human Necessities | 0 | Expired |
| US9145397B2 | Process for the preparation of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl)-L-proline-N, N-dimethylamide | Human Necessities | 0 | Active |
| US9073928B2 | Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3-methyl-4, 10-dihydro-3H-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide | Chemistry; Metallurgy | 0 | Active |
| US9079881B2 | Polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.